"Rheumatology" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A subspecialty of internal medicine concerned with the study of inflammatory or degenerative processes and metabolic derangement of connective tissue structures which pertain to a variety of musculoskeletal disorders, such as arthritis.
Descriptor ID |
D012219
|
MeSH Number(s) |
H02.403.429.730
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Rheumatology".
Below are MeSH descriptors whose meaning is more specific than "Rheumatology".
This graph shows the total number of publications written about "Rheumatology" by people in this website by year, and whether "Rheumatology" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1998 | 0 | 1 | 1 |
1999 | 1 | 1 | 2 |
2000 | 1 | 0 | 1 |
2003 | 2 | 0 | 2 |
2004 | 2 | 0 | 2 |
2005 | 2 | 0 | 2 |
2006 | 1 | 0 | 1 |
2007 | 1 | 0 | 1 |
2011 | 1 | 0 | 1 |
2012 | 1 | 1 | 2 |
2013 | 1 | 0 | 1 |
2014 | 2 | 0 | 2 |
2015 | 1 | 1 | 2 |
2016 | 4 | 1 | 5 |
2017 | 2 | 1 | 3 |
2018 | 1 | 0 | 1 |
2019 | 4 | 1 | 5 |
2020 | 1 | 0 | 1 |
2021 | 3 | 0 | 3 |
2022 | 9 | 0 | 9 |
2023 | 8 | 0 | 8 |
2024 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Rheumatology" by people in Profiles.
-
Consensus on the definitions and descriptions of the domains of the OMERACT Core Outcome Set for shared decision making interventions in rheumatology trials. Semin Arthritis Rheum. 2024 Apr; 65:152381.
-
Generating a list of potentially important contextual factors covering randomized trials, cohorts, and measurement property studies: An OMERACT initiative. Semin Arthritis Rheum. 2024 Apr; 65:152370.
-
OMERACT Core outcome measurement set for shared decision making in rheumatic and musculoskeletal conditions: a scoping review to identify candidate instruments. Semin Arthritis Rheum. 2024 Apr; 65:152344.
-
Patient outcomes in longitudinal observational studies (POLOS) of rheumatoid arthritis: Determining the OMERACT core domain set. Semin Arthritis Rheum. 2024 Feb; 64:152343.
-
Stakeholder endorsement advancing the implementation of a patient-reported domain for harms in rheumatology clinical trials: Outcome of the OMERACT Safety Working Group. Semin Arthritis Rheum. 2023 12; 63:152288.
-
The 2022 EULAR/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS). Ann Rheum Dis. 2023 10; 82(10):1271-1285.
-
Pediatric Rheumatology Care and Outcomes Improvement Network's Quality Measure Set to Improve Care of Children With Juvenile Idiopathic Arthritis. Arthritis Care Res (Hoboken). 2023 12; 75(12):2442-2452.
-
Trajectories of disease activity in patients with JIA in the Childhood Arthritis and Rheumatology Research Alliance Registry. Rheumatology (Oxford). 2023 02 01; 62(2):804-814.
-
2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases. Arthritis Care Res (Hoboken). 2023 03; 75(3):449-464.
-
2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases. Arthritis Rheumatol. 2023 03; 75(3):333-348.